News
The Egon Naef Foundation awards its 2023 prize to PD Dr Marco Alves
The Egon Naef Foundation for in vitro research has presented its 2023 prize to PD Dr Marco Alves of the IVI and the University of Bern. The researcher and his team have developed an in vitro model that demonstrates the infection of the human placenta by SARS-CoV-2.
Avian influenza
Research project: Vaccination of zoo birds against highly pathogenic viruses of the avian influenza (H5N1).
Releases
Java script is required to display press releases. If you are unable or unwilling to activate Java script you may use the link below to access the Federal Administration News Portal, where you can read the announcements.
In focus
Improved COVID-19 vector vaccine candidate
In a recent publication, scientists at the Institute of Virology and Immunology (IVI) and the University of Bern report on a Vesicular Stomatitis Virus (VSV)-vectored COVID-19 vaccine candidate.
Rabies
Rabies in Switzerland: a daily battle. If a case of rabies is suspected, prompt action is vital to protect potentially exposed humans against this deadly zoonosis.
Blog - Young researchers from the IVI
Silvio Steiner : “It was an incredibly exciting challenge to be at the centre of research in the early days of the SARS-CoV-2 pandemic and witness the latest findings live”.
Transfer of immunological veterinary medicinal products to Swissmedic
On 1 January 2023, responsibility for the authorisation, variation, batch release, market surveillance and licences for importing individual batches of immunological veterinary medicinal products was transferred from the Institute of Virology and Immunology (IVI) to Swissmedic.
In cooperation with Vetsuisse Faculty
www.ivi.unibe.ch